遺伝子導入技術市場レポート：2030年までの動向、予測、競合分析

遺伝子導入技術の動向と予測

世界の遺伝子導入技術市場は、2024年から2030年までのCAGR 14.6%で、2030年までに推定77億米ドルに達すると予想されています。この市場の主な促進要因は、慢性疾患の有病率の増加、標的治療薬に対する需要の増大、遺伝子と細胞の調査と治療法の提供の進歩です。世界の遺伝子導入技術市場の将来は、遺伝子治療、細胞治療、ワクチン、調査市場における機会により有望に見えます。

遺伝子導入技術市場に関する洞察

Lucintelは、キムリアとイエスカルタの大成功に伴うウイルスベクターベースの研究開発プログラムの増加により、生物学的分野が予測期間を通じて最大のセグメントであり続けると予測しています。

この市場内では、遺伝子ベースの治療の導入増加と臨床調査の取り組み数の増加により、遺伝子治療が引き続き最大のセグメントとなるでしょう。

北米は、臨床試験数の増加、遺伝子治療に対する患者の支出の増加、およびこの地域における大手企業の存在により、予測期間を通じて最大の地域であり続けると思われます。

よくある質問

Q1.市場規模は：

A1.世界の遺伝子導入技術市場は、2030年までに推定77億米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.世界の遺伝子導入技術市場は、2024年から2030年にかけて14.6%のCAGRで成長すると予想されています。

Q3.市場の成長に影響を与える主な促進要因は：

A3.この市場の主な促進要因は、慢性疾患の有病率の増加、標的治療薬に対する需要の増大、遺伝子と細胞の調査と治療法の提供の進歩です。

Q4.市場の主要セグメントは：

A4.遺伝子導入技術市場の将来は、遺伝子治療、細胞治療、ワクチン、調査市場における機会により有望に見えます。

Q5.市場の主要企業は：

A5.主要な遺伝子導入技術企業の一部は次のとおりです。

• Thermo Fisher Scientific
• QIAGEN
• Horizon Discovery
• OriGene Technologies
• Oxford Biomedica
• SignaGen Laboratories
• Vectalys

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、キムリアとイエスカルタの大成功に伴うウイルスベクターベースの研究開発プログラムの増加により、生物学的分野が予測期間を通じて最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は、臨床試験数の増加、遺伝子治療に対する患者の支出の増加、およびこの地域における大手企業の存在により、予測期間を通じて最大の地域であり続けると思われます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の遺伝子導入技術市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の遺伝子導入技術市場動向（2018-2023）と予測（2024-2030）
• モード別の世界の遺伝子導入技術市場
  • 生物学的
  • 化学的
  • 物理的
• 方法別の世界の遺伝子導入技術市場
  • 生体外
  • 生体内
  • 試験管内
• アプリケーション別の世界の遺伝子導入技術市場
  • 遺伝子治療
  • 細胞治療
  • ワクチン
  • 調査

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の遺伝子導入技術市場
• 北米の遺伝子導入技術市場
• 欧州の遺伝子導入技術市場
• アジア太平洋の遺伝子導入技術市場
• その他地域の遺伝子導入技術市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • モード別の世界の遺伝子導入技術市場の成長機会
  • 方法別の世界の遺伝子導入技術市場の成長機会
  • アプリケーション別の世界の遺伝子導入技術市場の成長機会
  • 地域別の世界の遺伝子導入技術市場の成長機会
• 世界の遺伝子導入技術市場における新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の遺伝子導入技術市場の能力拡大
  • 世界の遺伝子導入技術市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Thermo Fisher Scientific
• QIAGEN
• Horizon Discovery
• OriGene Technologies
• Oxford Biomedica
• SignaGen Laboratories
• Vectalys

Gene Delivery Technologies Trends and Forecast

The future of the global gene delivery technologies market looks promising with opportunities in the gene therapy, cell therapy, vaccines, and research markets. The global gene delivery technologies market is expected to reach an estimated $7.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases, growing demand for targeted therapeutics, and advancements in gene and cell research and therapeutic delivery.

A more than 150-page report is developed to help in your business decisions.

Gene Delivery Technologies by Segment

The study includes a forecast for the global gene delivery technologies by mode, method, application, and region.

Gene Delivery Technologies Market by Mode [Shipment Analysis by Value from 2018 to 2030]:

• Biological
• Chemical
• Physical

Gene Delivery Technologies Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Ex Vivo
• In Vivo
• In Vitro

Gene Delivery Technologies Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Gene Therapy
• Cell Therapy
• Vaccines
• Research

Gene Delivery Technologies Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Gene Delivery Technologies Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gene delivery technologies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gene delivery technologies companies profiled in this report include-

• Thermo Fisher Scientific
• QIAGEN
• Horizon Discovery
• OriGene Technologies
• Oxford Biomedica
• SignaGen Laboratories
• Vectalys

Gene Delivery Technologies Market Insights

Lucintel forecasts that biological will remain the largest segment over the forecast period due to growing number of viral vectors-based R&D programs along high success of Kymriah and Yescarta.

Within this market, gene therapy will remain the largest segment due to increasing adoption of gene-based therapies and growing number of clinical research initiatives.

North America will remain the largest region over the forecast period due to risng number of clinical trials, increasing expenditure of patients on gene therapies, and presence of major players in the region.

Features of the Global Gene Delivery Technologies Market

Market Size Estimates: Gene delivery technologies market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Gene delivery technologies market size by mode, method, application, and region in terms of value ($B).

Regional Analysis: Gene delivery technologies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different modes, methods, applications, and regions for the gene delivery technologies market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gene delivery technologies market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the gene delivery technologies market size?

Answer: The global gene delivery technologies market is expected to reach an estimated $7.7 billion by 2030.

Q2. What is the growth forecast for gene delivery technologies market?

Answer: The global gene delivery technologies market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the gene delivery technologies market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases, growing demand for targeted therapeutics, and advancements in gene and cell research and therapeutic delivery.

Q4. What are the major segments for gene delivery technologies market?

Answer: The future of the gene delivery technologies market looks promising with opportunities in the gene therapy, cell therapy, vaccines, and research markets.

Q5. Who are the key gene delivery technologies market companies?

Answer: Some of the key gene delivery technologies companies are as follows:

• Thermo Fisher Scientific
• QIAGEN
• Horizon Discovery
• OriGene Technologies
• Oxford Biomedica
• SignaGen Laboratories
• Vectalys

Q6. Which gene delivery technologies market segment will be the largest in future?

Answer: Lucintel forecasts that biological will remain the largest segment over the forecast period due to growing number of viral vectors-based R&D programs along high success of Kymriah and Yescarta.

Q7. In gene delivery technologies market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to risng number of clinical trials, increasing expenditure of patients on gene therapies, and presence of major players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the gene delivery technologies market by mode (biological, chemical, and physical), method (ex vivo, in vivo, and in vitro), application (gene therapy, cell therapy, vaccines, and research), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Gene Delivery Technologies Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Gene Delivery Technologies Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Gene Delivery Technologies Market by Mode
  • 3.3.1: Biological
  • 3.3.2: Chemical
  • 3.3.3: Physical
• 3.4: Global Gene Delivery Technologies Market by Method
  • 3.4.1: Ex vivo
  • 3.4.2: In vivo
  • 3.4.3: In vitro
• 3.5: Global Gene Delivery Technologies Market by Application
  • 3.5.1: Gene Therapy
  • 3.5.2: Cell Therapy
  • 3.5.3: Vaccines
  • 3.5.4: Research

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Gene Delivery Technologies Market by Region
• 4.2: North American Gene Delivery Technologies Market
  • 4.2.2: North American Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
• 4.3: European Gene Delivery Technologies Market
  • 4.3.1: European Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
  • 4.3.2: European Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
• 4.4: APAC Gene Delivery Technologies Market
  • 4.4.1: APAC Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
  • 4.4.2: APAC Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
• 4.5: ROW Gene Delivery Technologies Market
  • 4.5.1: ROW Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
  • 4.5.2: ROW Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Gene Delivery Technologies Market by Mode
  • 6.1.2: Growth Opportunities for the Global Gene Delivery Technologies Market by Method
  • 6.1.3: Growth Opportunities for the Global Gene Delivery Technologies Market by Application
  • 6.1.4: Growth Opportunities for the Global Gene Delivery Technologies Market by Region
• 6.2: Emerging Trends in the Global Gene Delivery Technologies Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Gene Delivery Technologies Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Gene Delivery Technologies Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: QIAGEN
• 7.3: Horizon Discovery
• 7.4: OriGene Technologies
• 7.5: Oxford Biomedica
• 7.6: SignaGen Laboratories
• 7.7: Vectalys